{
    "title": "Oxford Biomedica shares plummet by 15% as British vaccine manufacturer warns of lower annual revenues",
    "url": "https://www.dailymail.co.uk/money/markets/article-10734985/Oxford-Biomedica-shares-plummet-fifth-lower-revenue-warning.html",
    "date": "2022-04-20",
    "keywords": [
        "vaccine",
        "biomedica",
        "oxford",
        "year",
        "covid19",
        "cent",
        "business",
        "share",
        "group",
        "supply",
        "agreement",
        "market",
        "manufacturing",
        "investment",
        "fund",
        "ftse",
        "gene",
        "cell",
        "therapy",
        "loss",
        "material",
        "astrazeneca",
        "boss",
        "money",
        "stake",
        "development",
        "capital",
        "vector",
        "account",
        "fee",
        "maker",
        "productionoxford",
        "wednesday",
        "faller",
        "index",
        "gold",
        "miner",
        "petropavlovsk",
        "achievement",
        "growth",
        "revenue",
        "firm",
        "company",
        "drop",
        "result",
        "profit",
        "boom",
        "income",
        "increase",
        "employment",
        "costsoxford",
        "foot",
        "facility",
        "cowley",
        "oxfordshire",
        "oxbox",
        "september",
        "report",
        "country",
        "portfolio",
        "shot",
        "arm",
        "clutch",
        "city",
        "bt",
        "jan",
        "du",
        "article",
        "price",
        "data",
        "plant",
        "serum",
        "life",
        "contract",
        "hold",
        "place",
        "output",
        "operating",
        "research",
        "integration",
        "venture",
        "homology",
        "subsidiary",
        "order",
        "presence",
        "virus",
        "method",
        "division",
        "homologydr",
        "roch",
        "chair",
        "executive",
        "strategy",
        "leader",
        "success",
        "scope",
        "process",
        "ceo",
        "john",
        "dawson"
    ],
    "category": [
        "money",
        "markets"
    ]
}